SCIE期刊CARDIOVASCULAR DRUGS AND THERAPY 2024/2025影响因子:3.146 (CARDIOVASC DRUG THER) (0920-3206). (PHARMACOLOGY & PHARMACY

显示全部楼层 · 发表于 2025-3-23 11:22:24

Submitted on: 20 July 2019. Revised on: 18 September 2019. Accepted on: 16 October 2019. ___________________CARDIOVASCULAR DRUGS AND THERAPY

显示全部楼层 · 发表于 2025-3-23 15:00:40

Submitted on: 27 February 2017. Revised on: 30 March 2017. Accepted on: 18 April 2017. ___________________CARDIOVASCULAR DRUGS AND THERAPY

显示全部楼层 · 发表于 2025-3-23 21:20:38

显示全部楼层 · 发表于 2025-3-24 01:16:14

显示全部楼层 · 发表于 2025-3-24 05:05:55

显示全部楼层 · 发表于 2025-3-24 09:10:42

Submitted on: 23 November 2007. Revised on: 28 December 2007. Accepted on: 17 February 2008. ___________________CARDIOVASCULAR DRUGS AND THERAPY

显示全部楼层 · 发表于 2025-3-24 12:45:34

显示全部楼层 · 发表于 2025-3-24 15:04:04

Submitted on: 03 April 1999. Revised on: 01 June 1999. Accepted on: 20 June 1999. ___________________CARDIOVASCULAR DRUGS AND THERAPY

显示全部楼层 · 发表于 2025-3-24 21:29:13

Submitted on: 27 February 2013. Revised on: 27 June 2013. Accepted on: 21 July 2013. ___________________CARDIOVASCULAR DRUGS AND THERAPY

显示全部楼层 · 发表于 2025-3-25 01:36:08

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 16:16
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved